Skip to main navigation Skip to search Skip to main content

Mutations in the anti-sigma H factor RshA confer resistance to econazole and clotrimazole in Mycobacterium smegmatis

  • Héctor R. Morbidoni
  • , Agustina I. de la Iglesia
  • , Virginia Figueroa
  • , Cecilia Di Capua
  • , Thomas R. Ioerger
  • , Tanya Parish
  • Universidad Nacional de Rosario
  • Texas A&M University
  • TB Discovery Research
  • Infectious Disease Research Institute

Research output: Contribution to journalArticlepeer-review

Abstract

Azole drugs such as econazole, are active on Mycobacterium tuberculosis and Mycobacterium smegmatis; however, the identification of their target(s) is still pending. It has been reported that mutations in the non-essential system mmpL5-mmpS5 conferred resistance to econazole in M. tuberculosis. We herein report that an azole-resistant mutant screen in M. smegmatis rendered mutations in rshA, encoding a non-essential anti-sigma H protein.

Original languageEnglish
Article number000070
JournalAccess Microbiology
Volume1
Issue number10
DOIs
Publication statusPublished - 1 Dec 2019
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • econazole
  • Mycobacterium smegmatis
  • Mycobacterium tuberculosis
  • RshA

Fingerprint

Dive into the research topics of 'Mutations in the anti-sigma H factor RshA confer resistance to econazole and clotrimazole in Mycobacterium smegmatis'. Together they form a unique fingerprint.

Cite this